Overview

Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivity Disorder

Status:
Completed
Trial end date:
1999-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety and effectiveness of OROS® Methylphenidate HCl (a central nervous system stimulant) in children with attention deficit hyperactivity disorder (ADHD).
Phase:
Phase 3
Details
Lead Sponsor:
Alza Corporation, DE, USA
Treatments:
Methylphenidate